Answers are grounded in this paper and cite their sources.
Evaluates skin wound dressing efficacy in chronic wound treatment, highlighting a promising alternative.
) of weight loss associated with hydrolysis of CS/PVA. No cytotoxic effects were observed in human dermal fibroblasts (HDFs) from primary culture stained with calcein and ethidium homodimer, confirming cell viability of more than 95% and indicating cell attachment which did not require additional coatings or interfaces between SIPNs and seeded cells. HDFs were also able to spread, showing fusiform morphologies and cell confluence. Proliferation, via DNA quantification, increased with PDMS ratio: 247 ± 11 ng/mL (SIPN 7:3), 197 ± 5 ng/mL (5:5), and 142 ± 8 ng/mL (3:7). Subdermal implants formed connective tissue pseudo-capsules over four weeks, absent multinucleated giant cells indicative of foreign body reactions. SIPN 7:3 matched commercial dressings in wound closure, wound length, collagen synthesis, and neo-vascularization, outperforming in blood vessel count at day 7 -statistically significant- and equaling at day 14 versus control. SIPN 7:3 offers commercial-level efficacy, hyperelasticity, adaptability to irregular sites, and transparency for monitoring, positioning it as a promising alternative for chronic wound treatment.
No takes yet. Share an insight, caveat, or question.
Vázquez‐Torres et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: